🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to assess the immunogenicity, safety and reactogen...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-10-14
Trial ID
NCT05568797
Treatments Being Tested
This study includes 3 parts: Parts A, B, and C. The purpose of this study i...
Status
Completed
Location
Pinnacle Research Group
Start Date
2023-04-17
Trial ID
NCT05827978
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety, and re...
Status
Completed
Location
Pinnacle Research Group-409 E 10th St
Start Date
2023-10-19
Trial ID
NCT06097273
Treatments Being Tested
The primary objective of this study is to demonstrate the immunologic nonin...
Status
Completed
Location
Research Site
Start Date
2010-03
Trial ID
NCT01091246
Treatments Being Tested
This study evaluates whether priming influenza naive infants, age six to 23...
Status
Completed
Location
Vaccine Evaluation Center, BC Children's Hospital
Start Date
2018-11-01
Trial ID
NCT03669627
Treatments Being Tested
The aim of this clinical trial is to explore the efficacy of fatty acid and...
Status
Not Yet Recruiting
Location
Tsinghua University
Start Date
2025-02
Trial ID
NCT06827873
A Phase 3, randomized, observer-blinded, active-controlled trial to evaluat...
Status
Completed
Location
US135
Start Date
2019-10-14
Trial ID
NCT04120194
Treatments Being Tested
The primary objectives of this study are to evaluate the humoral immunogeni...
Status
Completed
Location
CEI -Centro de Estudios Infectológicos
Start Date
2022-06-06
Trial ID
NCT05415462
Treatments Being Tested
The ability of the vaccines today to generate a long-lasting protection aga...
Status
Recruiting
Location
Emory University Hospital
Start Date
2023-04-11
Trial ID
NCT05801978
Treatments Being Tested
A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical S...
Status
Completed
Location
MHAT St. Ekaterina
Start Date
2016-09-30
Trial ID
NCT02587221